Company profile: Abbott
1.1 - Company Overview
Company description
- Provider of lab data management solutions, including LIMS, SDMS, and ELN, that integrate with current systems and can be rapidly configured to fit unique workflows without adding complexity or interrupting daily operations.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Abbott
Reify Health
HQ: United States
Website
- Description: Provider of cloud-based tools for the clinical trial ecosystem, including OneStudyTeam, a platform connecting research sites, sponsors, patients, and other stakeholders to improve collaboration, enrollment, and trial management, and Care Access, an initiative integrating new-to-research physicians and practices to expand trial access for underserved communities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reify Health company profile →
Frontier Medicines
HQ: United States
Website
- Description: Provider of a biopharmaceutical drug discovery platform integrating chemoproteomics, covalent chemistry, and machine learning to accelerate medicine development; programs include a dual KRASG12C inhibitor (FMC-376) targeting active and inactive forms in cancers and AutoTAC for autophagy-driven targeted degradation; tools span ML/AI prioritization, chemoproteomics to identify druggable hotspots, and a covalent fragment library.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Frontier Medicines company profile →
Jumpcode Genomics
HQ: United States
Website
- Description: Provider of CRISPR-mediated rRNA and DNA depletion kits for sequencing workflows, improving sensitivity and performance. Solutions include single-cell RNA boost kits (CRISPRclean, DepleteX) to remove uninformative transcripts and undesired fragments; bulk RNA/DNA depletion for stranded RNA-Seq; mitochondrial DNA, nasopharyngeal RNA, and human DNA depletion to enhance genomic and microbial analyses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jumpcode Genomics company profile →
RxData
HQ: United States
Website
- Description: Provider of a global market access data platform offering on-demand, automated pharmaceutical pricing and reimbursement insights. Solutions include comprehensive market access intelligence, exportable dashboards, real-time monitoring of 100+ sources, curated HTA/regulatory data, visible net price algorithms, and an internal data repository.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RxData company profile →
Szabo-Scandic
HQ: Austria
Website
- Description: Provider of biochemicals, research and diagnostics products, laboratory instruments, cell culture and consumables, offering distribution and servicing of consumables, research reagents, laboratory instruments and specific diagnostics for the Austrian life science market.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Szabo-Scandic company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Abbott
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Abbott
2.2 - Growth funds investing in similar companies to Abbott
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Abbott
4.2 - Public trading comparable groups for Abbott
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →